Home › NDC Lookup › RxCUI directory › RxCUI 309049

Cefadroxil 500 MG Oral Capsule — RxCUI 309049

Name: Cefadroxil 500 MG Oral Capsule (RxCUI 309049)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 309049 Semantic clinical drug · SCD ● Current RxNorm concept 31 FDA products 62 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309049

Official nameCefadroxil 500 MG Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule

FDA products mapped31

Package NDCs mapped62

Reported Medicaid activity (SDUD)114,278 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefadroxil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cefadroxil is used to treat three main types of bacterial infections: urinary tract infections (UTIs), skin and skin structure infections, and strep throat or tonsillitis caused by...
What kind of infections does cefadroxil actually treat?
You can take it with or without food — it's absorbed fine either way. That said, if you notice any nausea or stomach upset, taking it with a meal or snack can help settle things do...
This is really important to flag with your doctor before you start. Cefadroxil and penicillin belong to related antibiotic families, and up to about 1 in 10 people with a penicilli...

📖 Read our full Cefadroxil guide →

🕸️ Concept Web — How Cefadroxil 500 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cefadroxil 500 MG Oral Capsule RxCUI 309049 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Cefadroxil 2177 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cefadroxil Oral Capsule 371316 SCDF
- Cefadroxil Oral Product 1152088 SCDG
- Cefadroxil Pill 1152089 SCDG
- Oral Capsule 316965 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cefadroxil 500 MG 315593 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cefadroxil 500 MG SCDC · 315593
Cefadroxil Oral Capsule SCDF · 371316
Cefadroxil Oral Product SCDG · 1152088
Cefadroxil Pill SCDG · 1152089

📦 FDA Products & Package NDCs

31 products · 62 package NDCs

62 package NDCs map to RxCUI 309049 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
72189-0445-20	20 CAPSULE in 1 BOTTLE (72189-445-20)	Cefadroxil	Direct_Rx	2023-03-14
72189-0506-06	6 CAPSULE in 1 BOTTLE (72189-506-06)	Cefadroxil	Direct_Rx	2023-08-07
72189-0506-20	20 CAPSULE in 1 BOTTLE (72189-506-20)	Cefadroxil	Direct_Rx	2023-08-07
80425-0198-01	10 CAPSULE in 1 BOTTLE (80425-0198-1)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2023-11-02
80425-0198-02	30 CAPSULE in 1 BOTTLE (80425-0198-2)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2023-11-02
80425-0198-03	20 CAPSULE in 1 BOTTLE (80425-0198-3)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2024-02-09
80425-0400-01	10 CAPSULE in 1 BOTTLE (80425-0400-1)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2024-06-07
80425-0400-02	20 CAPSULE in 1 BOTTLE (80425-0400-2)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2024-06-07
80425-0400-03	30 CAPSULE in 1 BOTTLE (80425-0400-3)	Cefadroxil	Advanced Rx Pharmacy of Tennessee, LLC	2024-06-07
80425-0432-01	10 CAPSULE in 1 BOTTLE (80425-0432-1)	Cefadroxil	Advanced Rx of Tennessee, LLC	2024-08-23
80425-0432-02	20 CAPSULE in 1 BOTTLE (80425-0432-2)	Cefadroxil	Advanced Rx of Tennessee, LLC	2024-08-23
80425-0432-03	30 CAPSULE in 1 BOTTLE (80425-0432-3)	Cefadroxil	Advanced Rx of Tennessee, LLC	2024-08-23

Observed labelers: Advanced Rx Pharmacy of Tennessee, LLC (6) · NuCare Pharmaceuticals,Inc. (6) · PD-Rx Pharmaceuticals, Inc. (6) · Redpharm Drug (6) · Bryant Ranch Prepack (4) · Direct_Rx (4) · +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.2843

Range $0.2843–$0.2843 · middle 50% $0.2843–$0.2843 · 10 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.